Implant restores visual perception in blind patients

Article

A subretinal implant has been shown to restore some vision in patients blinded by hereditary retinal degeneration.

A subretinal implant has been shown to restore some vision in patients blinded by hereditary retinal degeneration according to a study published in the Proceedings of The Royal Society B.

The subretinal micro-electrode arrays with 1500 photodiodes was shown to improve visual function from a state of complete blindness enabling recognition of objects up to letters and words..

The research, led by Dr Eberhart Zrenner et al. from the University of Tübingen, was a clinical pilot study examining the efficacy of a light sensitive, externally powered microchip implanted subretinally in three patients with hereditary blindness. The implant contains an array of 1500 active microphotodiodes that each have an amplifier and local stimulation electrode. In addition to this, the tip of the implant contains a further 16 wire-connected electrodes that allow light-independent direct stimulation and testing of the neuron–electrode interface.

Naturally, images are projected through the eye and onto the microphotodiodes through the retina. There was a corresponding pattern produced by the implant sending light-intensity dependent electric stimulation pulses to the patient.

The results demonstrated strong evidence towards the ability of the implant to improve the patient’s visual functions allowing the three patients involved to locate bright objects on a dark table. One patient could even correctly describe and name the shapes as well as finding and approaching persons within a room and reading large letters as complete words.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.